of biogenic amines and peptides on urine outflow and ADH release were studied using intracerebroventricular (i.c.v.) perfusion experiments and isolated neurohypophysis incubation studies. Decrease in the urine outflow was observed after norepinephrine, histamine and angiotensin II had been administered i.c.v.. The effect of norepinephrine was prevented by phentolamine.
Norepinephrine (also probably dopamine)-containing nerve terminals have been found in the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus (1) . Antidiuretic hormone (ADH) produced in the nerve cells in the SON and PVN is transported to the posterior lobe of the pituitary. It seems likely, therefore, that an adre nergic mechanism is implicated in the production and secretion of ADH. In fact, centrally administered norepinephrine stimulated the release of ADH (2) (3) (4) . Although relatively high concentrations of histamine (5-7) and angiotensin (8) are found in the brain, particularly in the hypothalamus, little is known about their role in the mechanisms of ADH release.
The present experiments dealt with possible roles of these biogenic amines and the peptides on the central antidiuresis using an intracerebroventricular (i.c.v.) perfusion technique in rats.
Whether or not biogenic amines and peptides stimulate directly the release of ADH from the isolated neurohypophysis was also studied. It has earlier been shown that angio tensin II increases the ADH release from the isolated neurohypophysis (9) , and it was sug gested that the antidiuretic effect of bradykinin was due to its action on the central nervous system, although bradykinin did not cause a release of ADH from the isolated preparation (10) . Furthermore, there is no data which suggests that the amines stimulated directly the neurohypophysis to increase the ADH release. Intracerebroventricular perfusion study: Male Wistar rats, weighing between 280 g to 300 g, were fasted for about 18 hr but allowed free access to drinking water. The animals were loaded with oral water at volumes of 5 ml/100 g followed 45 min later by a oral dose of 5 ml/100 g of 12 ° ethanol in a 0.9 % NaCI solution. The tracheal cannulation was set and the bladder was catheterized after a suprapubic incision. The other side of the catheter was connected to a photoelectric drop counter to record urine outflow (one drop of urine= 23 //l).
Ethanol (3 ° , in saline) was infused at a constant rate of 0. 1 ml/min through an external jugular venous cannula for maintenance of anaesthesis and diuresis. Thereafter, the animals were placed prone in a stereotaxic frame. Steel cannulae with 0.27 mm of an inner diameter 
RESULTS
Intracerebroventricular perfusion study: Nearly 1.5-2 hr after starting the perfusion, the perfusate outflow rate, protein concentrations in the perfusate, protein output rate and urine outflow rate attained a steady-state which could be continued for more than 4 hours. shows time-courses for the antidiuretic actions of norepinephrine and phentolamine and the prevention of norepinephrine-induced antidiuresis by phentolamine.
Histamine caused a remarkable antidiuresis at doses ranging from 2 x 10-9 moles to 10_v mole in 10 tl (Fig. 4) . A typical time-course for the histamine-induced antidiuresis is represented in Fig. 5A . When injected i.c.v., none of drugs tested changed rectal temperature. When these drugs were injected i.v. at same doses given i.c.v., there was no change in urine outflow.
Isolated neurohypophysis incubation experiment: Table 1 shows that amounts of A comparison was made among biogenic amines, such as norepinephrine, histamine, serotonin and dopamine on the potency for the ADH release from isolated neurohypophysis (Table 2) . When the neural lobe was incubated in the presence of norepinephrine and histamine at a concentration of 50 ,FPM, the release of ADH was significantly increased at 2.8 % and 4.3 °/, respectively. Neither serotonin nor dopamine increased the ADH release at concentrations used. The increase in the ADH release by norepinephrine and histamine could be prevented by phentolamine and promethazine, respectively, while phentolamine alone increased significantly the ADH release, but promethazine did not change the release of ADH (Table 3 ).
The increased release of ADH was observed by angiotensin II amide 5-valine at a concentration of I /CM. The same concentration of angiotensin II 5-isoleucine, however, was without effect. In addition, bradykinin at a concentration of 50 16M increased sig nificantly the ADH release (Table 4) .
The amines and peptides at amounts at which contained in the incubation medium, did not produce antidiuresis, when injected i.v. in the ethanol-anaesthetized rat.
DISCUSSION
In order to study the antidiuretic effects of biogenic amines and peptides in the cerebro ventricular system, a perfusion method has been devised using rats.
Since the PVN and a part of the SON are situated close to the wall of the 3rd ventricle, it could be assumed that chemicals would act on these nuclei to release ADH. In addition, since urine flow may be influenced by systemic blood pressure, the pressure was recorded when i.c.v. injections of drugs were given and it was found that norepinephrine, histamine and angiotensin It were potent antidiuretics at doses less than those which altered blood pressure. Even when i.c.v. administered drugs decreased the urine outflow rate, perfusate flow rate, protein concentration in the perfusate and rectal temperature did not vary.
Since norepinephrine (1), histamine (5-7) and angiotensin (8) are fairly abundant in the hypothalamus, the antidiuretic potencies were tested. We found that the antidiuretic effect of norepinephrine, histamine and angiotensin II was not peripheral but rather central in origin, as antidiuresis was not produced when these agents were injected i.v. at the same doses as those infused i.c.v.. The present work shows that norepinephrine and histamine increased the release of ADH from the isolated neural lobe. Such findings suggest that circulating amines would directly stimulate the neural lobe to increase the release of ADH. In fact, we previously observed that histamine given i.v. decreased urine outflow and that this response was in hibited by promethazine (20) . Furthermore, epinephrine given i.v. potentiated the anti diuretic response to acetylcholine also given i.v. (21) . It appears that the secretion of ADH from the neurohypophysis may be also regulated by the increase in local con centrations of catecholamine, and this regulation may occur, at least in part, through a adrenergic mechanisms, since the increase in the ADH release by the amine was inhibited by phentolamine. Phentolamine alone, slightly but significantly, increased the ADH release.
Serotonin and dopamine did not elicit increase in the release of ADH from the isolated lobe, suggesting that these agents were not involved in mechanisms controlling the ADH release in the lobe.
Bonjour and Malvin (22) demonstrated that systemic administration of angiotensin II caused an increase in the level of plasma ADH, and Gagnon et al. (9) provided evidence that ADH liberation from isolated neurohypophysis was increased by angiotensin II. Additional ly, although bradykinin given through the intracarotid artery route rather than intravenously was more effective in an increment of blood ADH concentrations, direct stimulation by the kinin of the pituitary was not observed (10) . On the other hand, we observed that angiotensin II amide 5-valine and bradykinin promoted the release of ADH from the isolated neural lobe. The finding that angiotensin II 5-isoleucine did not release ADH from the isolated lobe presents a discrepancy.
It was thus concluded that when local concentrations of amines and peptides are in creased near the pituitary, the release of ADH should be promoted. It was also suggested that norepinephrine, histamine and angiotensin II could be nominated as candidates for chemical transmitters of the ADH release in the rat hypothalamus.
